Concepedia
Statistics
Publications
7
Citations
365
H-Index
Active since
1999
Affiliations
Abbott Fund(Current)
AbbVie (United States)
University of Delaware
Steven L. Swann is an author at Abbott Fund specializing in drug design, pharmacy, and ligand binding.
Publications per year
1999–2020
Critical Aspartic Acid Residues in Pseudouridine Synthases
Vidhyashankar Ramamurthy, Steven L. Swann, Jennifer Paulson et al. · Journal of Biological Chemistry · 1999 · 102 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +13
A Unified, Probabilistic Framework for Structure- and Ligand-Based Virtual Screening
Steven L. Swann, Scott P. Brown, Steven W. Muchmore et al. · Journal of Medicinal Chemistry · 2011 · 91 citations
Pharmacy, Bioinformatics, Medicinal Chemistry +16
Fragment-based discovery of potent inhibitors of the anti-apoptotic MCL-1 protein
Andrew M. Petros, Steven L. Swann, Danying Song et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 80 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +16
Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug Design
Justin Dietrich, Kenton L. Longenecker, Noel S. Wilson et al. · Journal of Medicinal Chemistry · 2020 · 45 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Role of Cysteine Residues in Pseudouridine Synthases of Different Families
Vidhyashankar Ramamurthy, Steven L. Swann, Christopher J. Spedaliere et al. · Biochemistry · 1999 · 20 citations
Life Sciences, Biochemistry, Molecular Biology +12
1–5 of 7